JSPR vs. NVDA

Last updated Jun 23, 2026

JSPR (Jasper Therapeutics, Inc.) and NVDA (NVIDIA Corporation) are both stocks. JSPR operates in Biotechnology (Healthcare), while NVDA operates in Semiconductors (Technology). Over the past 3 years, JSPR returned -65.95%/yr vs 70.46%/yr for NVDA. At a 0.16 correlation, their price movements are largely independent.

Performance

JSPR vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jasper Therapeutics, Inc. (JSPR) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JSPR achieves a -72.60% return, which is significantly lower than NVDA's 12.01% return.

JSPR

• 1D: 10.71%
• 1M: -44.46%
• YTD: -72.60%
• 6M: -73.74%
• 1Y: -90.26%
• 3Y*: -65.95%
• 5Y*: —
• 10Y*: —

NVDA

• 1D: -0.97%
• 1M: -2.99%
• YTD: 12.01%
• 6M: 13.73%
• 1Y: 45.24%
• 3Y*: 70.46%
• 5Y*: 61.50%
• 10Y*: 68.65%

*Multi-year figures are annualized to reflect compound growth (CAGR)

JSPR vs. NVDA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
JSPR Jasper Therapeutics, Inc.	-72.60%	-91.44%	170.98%	63.39%	-93.85%	-37.90%
NVDA NVIDIA Corporation	12.01%	38.92%	171.25%	239.02%	-50.26%	30.84%

Correlation

The correlation between JSPR and NVDA is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.19
Correlation (All Time) Calculated using the full available price history since Sep 24, 2021	0.16

Fundamentals

Market Cap JSPR : $14.38M NVDA : $5.09T
EPS JSPR : -$2.87 NVDA : $6.53
PB Ratio JSPR : 4.23 NVDA : 26.04
Total Revenue (TTM) JSPR : $0.00 NVDA : $253.49B
Gross Profit (TTM) JSPR : -$290.00K NVDA : $187.95B
EBITDA (TTM) JSPR : -$72.26M NVDA : $192.76B

Return for Risk

JSPR vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JSPR

JSPR Risk / Return Rank: 6
JSPR Sharpe Ratio Rank: 8
JSPR Sortino Ratio Rank: 3
JSPR Omega Ratio Rank: 2
JSPR Calmar Ratio Rank: 3
JSPR Martin Ratio Rank: 14

NVDA

NVDA Risk / Return Rank: 76
NVDA Sharpe Ratio Rank: 78
NVDA Sortino Ratio Rank: 74
NVDA Omega Ratio Rank: 71
NVDA Calmar Ratio Rank: 78
NVDA Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JSPR vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jasper Therapeutics, Inc. (JSPR) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	JSPR	NVDA	Difference
Sharpe ratio: Return per unit of total volatility	-0.85	1.29	-2.14
Sortino ratio: Return per unit of downside risk	-1.88	1.86	-3.74
Omega ratio: Gain probability vs. loss probability	0.73	1.22	-0.49
Calmar ratio: Return relative to maximum drawdown	-0.97	2.25	-3.22
Martin ratio: Return relative to average drawdown	-1.23	5.27	-6.50

JSPR vs. NVDA - Sharpe Ratio Comparison

The current JSPR Sharpe Ratio is -0.85, which is lower than the NVDA Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of JSPR and NVDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

JSPR vs. NVDA - Drawdown Comparison

The maximum JSPR drawdown since its inception was -99.72%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for JSPR and NVDA.

Drawdown Indicators

	JSPR	NVDA	Difference
Max Drawdown Largest peak-to-trough decline	-99.72%	-89.72%	-10.00%
Max Drawdown (1Y) Largest decline over 1 year	-93.37%	-20.21%	-73.16%
Max Drawdown (3Y) Largest decline over 3 years	-98.49%	-36.88%	-61.61%
Max Drawdown (5Y) Largest decline over 5 years	—	-66.34%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-66.34%	—
Current Drawdown Current decline from peak	-99.69%	-11.39%	-88.30%
Average Drawdown Average peak-to-trough decline	-88.49%	-36.16%	-52.33%
Ulcer Index Depth and duration of drawdowns from previous peaks	73.29%	8.61%	+64.68%

Volatility

JSPR vs. NVDA - Volatility Comparison

Jasper Therapeutics, Inc. (JSPR) has a higher volatility of 48.15% compared to NVIDIA Corporation (NVDA) at 12.78%. This indicates that JSPR's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JSPR	NVDA	Difference
Volatility (1M) Calculated over the trailing 1-month period	48.15%	12.78%	+35.37%
Volatility (6M) Calculated over the trailing 6-month period	76.45%	26.61%	+49.84%
Volatility (1Y) Calculated over the trailing 1-year period	106.07%	35.31%	+70.76%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	241.69%	51.80%	+189.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	241.69%	49.89%	+191.80%

Dividends

JSPR vs. NVDA - Dividend Comparison

JSPR has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.13%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JSPR Jasper Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVDA NVIDIA Corporation	0.13%	0.02%	0.03%	0.03%	0.11%	0.05%	0.12%	0.27%	0.46%	0.29%	0.45%	1.20%

Financials

Frequently Asked Questions

Can I hold both JSPR and NVDA in my portfolio?

JSPR and NVDA have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JSPR or NVDA?

JSPR has higher volatility (48.15%) compared to NVDA (12.78%). In terms of maximum drawdown, JSPR dropped -99.72% vs NVDA's -89.72%.

Which has better risk-adjusted returns?

NVDA currently has the higher Sharpe Ratio (1.29 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.